A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML
| Autor: | Jonas, Brian A. a, ⁎, Potter, Laura A. b, Galkin, Maria c, Tuscano, Joseph M. a |
|---|---|
| Zdroj: | In Leukemia Research Reports 2023 19 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|